17:35 IST
BSE
Annual General Meeting
Novartis India Annual General Meeting
Novartis India issued a corrigendum to its 78th AGM notice. This correction clarifies ESOP 2026 scheme details and the company's nature of industry.
Novartis India Ltd
- Share price
- ₹2,011.30
- Market cap
- ₹4,966 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- 50.8×Sector 47.3×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 4Financial Results 4Annual General Meeting 4Open Offer 3Business Update 3Board Meeting Outcome 3Promoter Selling (Off-Market) 2Earnings Call 2Promoter Reclassification 1Promoter Buying (Off-Market) 1Partnership 1Merger & Restructuring 1Management Change 1Debt & Borrowing 1Capital Structure Change 1Board Meeting Date 1Acquisition 1
Time
4 announcements with these filters
21:07 IST
BSE
Annual General Meeting
Novartis India Annual General Meeting
Novartis India Limited submits its Annual Report for FY 2025-26 and notice for the 78th Annual General Meeting scheduled on September 24, 2026.
14:39 IST
BSE
Annual General Meeting
Novartis India Annual General Meeting
Novartis India shareholders approved Ms. Gowree Gokhale's appointment as Independent Director for five years via postal ballot. The resolution passed with a 99.97% majority vote.
- Execution
- 5 years
17:23 IST
BSE
Annual General Meeting
Novartis India Annual General Meeting
Novartis India Limited has issued a Postal Ballot notice to seek shareholder approval for the appointment of Ms. Gowree Gokhale as a Non-Executive Independent Director for a five-year term. E-voting commences on April 17, 2026, and concludes on May 16, 2026. This follows the upcoming conclusion of Ms. Sandra Martyres' tenure.
- Execution
- 5 years